Literature DB >> 3769957

Clinical significance of supraventricular tachyarrhythmias after acute myocardial infarction.

M Zoni Berisso, A Ferroni, E De Caro, L Carratino, G S Mela, C Vecchio.   

Abstract

160 survivors of acute myocardial infarction (AMI) were evaluated to assess the clinical significance of supraventricular tachyarrhythmias (SVTA) occurring at discharge from the hospital after the acute event. All the variables considered for the study were estimated before hospital discharge; arrhythmias were quantified with a 24 h Holter ECG monitoring system. SVTA occurred in 88 patients (55%). Single or repetitive supraventricular premature beats were found in 65 (41%), paroxysmal atrial or junctional tachycardias in 20 (12%), bouts of atrial flutter or fibrillation in 3 (2%). Bivariate statistical analysis showed no relationship between sex, previous cardiovascular history, type, and location of AMI and SVTA occurrence. A close positive relationship was found between age, left atrial dimension (LAD), cardio-thoracic ratio (CTR) and SVTA occurrence; an inverse relationship was found for left ventricular ejection fraction (LVEF). The presence of SVTA appeared significantly related to age above 55 years, to LAD greater than 40 mm, to LVEF less than 45%, to serum creatine kinase peak levels over 1400 U l-1 and to CTR over 0.49. Multivariate statistical analysis showed that five variables are important in discriminating patients suffering from SVTA: age, LAD, LVEF, left ventricular fractional shortening, and CTR. SVTA occurring at discharge from hospital after AMI are indicative of impaired left ventricular pump function.

Entities:  

Mesh:

Year:  1986        PMID: 3769957     DOI: 10.1093/oxfordjournals.eurheartj.a062135

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  3 in total

Review 1.  Current management of symptomatic atrial fibrillation.

Authors:  K S Channer
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Cardiopulmonary predictors of mortality in patients with COVID-19: What are the findings?

Authors:  Hoda Kavosi; Sepehr Nayebi Rad; Reza Atef Yekta; Zahra Tamartash; Mahboubeh Dini; Zahra Javadi Nejad; Leila Aghaghazvini; Ali Javinani; Amir Mohammad Mohammadzadegan; Seyedeh Zahra Fotook Kiaei
Journal:  Arch Cardiovasc Dis       Date:  2022-06-08       Impact factor: 3.196

3.  Long-term mortality risk in individuals with atrial or ventricular premature complexes (results from the Third National Health and Nutrition Examination Survey).

Authors:  Waqas Qureshi; Amit J Shah; Taufiq Salahuddin; Elsayed Z Soliman
Journal:  Am J Cardiol       Date:  2014-04-16       Impact factor: 2.778

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.